Lavipharm S.A. (LAVI.AT)

EUR 0.75

(-1.7%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 114.84 Million 114.34 Million 52.98 Million 50.99 Million 49.88 Million 41.89 Million
Total Current Assets 45.65 Million 45.6 Million 25.96 Million 23.34 Million 20.67 Million 18.62 Million
Cash And Short Term Investments 8.43 Million 18.24 Million 1.63 Million 1.93 Million 1.73 Million 1.84 Million
Cash and Cash Equivalents 8.43 Million 18.24 Million 1.63 Million 1.93 Million 1.73 Million 1.84 Million
Short Term Investments 3000.00 1000.00 - - - -
Net Receivables 16.56 Million 15.42 Million 14.47 Million 12.3 Million 12.45 Million 11.87 Million
Inventory 18.57 Million 10.9 Million 9.58 Million 8.76 Million 6.48 Million 4.9 Million
Other Current Assets 2.07 Million 1.02 Million 258 Thousand 340 Thousand -1000.00 -
Total Non-Current Assets 69.19 Million 68.74 Million 27.02 Million 27.65 Million 29.2 Million 23.27 Million
Net PPE 19.54 Million 17.05 Million 16.71 Million 16.42 Million 16.43 Million 15.32 Million
Good Will And Intangible Assets 44.54 Million 46.19 Million 3.13 Million 3.49 Million 3.41 Million 2.66 Million
Good Will - - - - - -
Intangible Assets 44.54 Million 46.19 Million 3.13 Million 3.49 Million - -
Long-Term Investments 3.71 Million 2.82 Million 3.12 Million 3.03 Million 2.96 Million 2.68 Million
Tax Assets 1.31 Million 2.55 Million 3.3 Million 4.7 Million 5.98 Million 2.27 Million
Other Non Current Assets 82 Thousand 126 Thousand 746 Thousand - 406 Thousand 320 Thousand
Other Assets - - - - - -
Total Liabilities 72.07 Million 74.03 Million 62.92 Million 62.64 Million 64.25 Million 61.39 Million
Total Current Liabilities 35.8 Million 45.74 Million 23.23 Million 18.8 Million 17.35 Million 14.66 Million
Account Payables 9.84 Million 7.65 Million 6.25 Million 4.42 Million 6.65 Million 4.19 Million
Tax Payables 242 Thousand 509 Thousand 101 Thousand 137 Thousand 127 Thousand 99 Thousand
Short Term Debt 3.5 Million 19.42 Million 4.21 Million 3.93 Million 2.97 Million 2.04 Million
Deferred Revenue 1.73 Million 1.01 Million 1.51 Million 1.74 Million 3.46 Million 2.11 Million
Other Current Liabilities 20.71 Million 17.64 Million 11.25 Million 8.7 Million 4.26 Million 6.3 Million
Total Non Current Liabilities 36.27 Million 28.29 Million 39.68 Million 43.83 Million 46.9 Million 46.73 Million
Long-Term Debt 12.69 Million 3.95 Million 21.83 Million 23.96 Million 25.65 Million 26.69 Million
Deferred Revenue Non Current 10.99 Million 10.98 Million 11.27 Million 11.52 Million 12.07 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 12.51 Million 13.17 Million 6.33 Million 7.84 Million 8.7 Million 20.03 Million
Other Liabilities 1.00 - - - 1.00 1.00
Total Equity 42.77 Million 40.31 Million -9.93 Million -11.64 Million -14.37 Million -19.5 Million
Stock Holders Equity 42.73 Million 40.27 Million -9.97 Million -11.67 Million -14.4 Million -19.52 Million
Common Stock 50.36 Million 50.36 Million 51.08 Million 51.08 Million 51.08 Million 51.08 Million
Retained Earnings -32.59 Million -34.26 Million -162.11 Million -163.83 Million -166.42 Million -171.75 Million
Accumulated other comprehensive income 17.55 Million 16.76 Million 16.63 Million 16.65 Million 16.52 Million 16.72 Million
Common Stock Equity 42.73 Million 40.27 Million -9.97 Million -11.67 Million -14.4 Million -19.52 Million
Capital Lease Obligation 10.99 Million 10.98 Million 11.27 Million 11.52 Million 12.08 Million 11.8 Million
Total Investments 3.71 Million 2.82 Million 3.12 Million 3.03 Million 2.96 Million 2.68 Million
Total Debt 27.2 Million 34.36 Million 37.32 Million 39.42 Million 40.71 Million 40.54 Million
Net Debt 18.76 Million 16.12 Million 35.69 Million 37.49 Million 38.98 Million 38.7 Million

Balance Sheet Charts